Athyrium Opportunities III Co-Invest 1 LP - Significant Ownership

Signature - Title
Athyrium Opportunities III Co-Invest 1 LP - Senior Vice President, Secretary of Athyrium Opportunities Associates Co-Invest LLC, general partner of Athyrium Opportunities III Co-Invest 1 LP
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Athyrium Opportunities III Co-Invest 1 LP.

Significant Ownership of Athyrium Opportunities III Co-Invest 1 LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOR Biora Therapeutics, Inc. Common Stock, par value $0.001 per share 49.9% $547K 3.42M Jeffrey A. Ferrell Mar 24, 2025

Schedules 13D/G Reported by Athyrium Opportunities III Co-Invest 1 LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.